KLN Logistics Group Limited announced that its pharmaceutical division, KLN Pharma (Hong Kong) Limited, has been appointed as the fourth-party logistics (4PL) provider for Australian skincare brand Ego Pharmaceuticals in Hong Kong.
KLN Pharma will manage Ego’s entire supply chain, including domestic distribution to retail outlets, pharmacies, and key chain channels. Using GMP-compliant facilities, multi-temperature storage, and advanced inventory systems, KLN Pharma will ensure product integrity and regulatory compliance from inbound logistics to final delivery. The partnership also covers marketing logistics, supporting product launches and promotional campaigns.
Samuel Lau, KLN’s Managing Director – Integrated Logistics, said, “Our 4PL model delivers the agility, compliance, and scalability needed to support Ego’s growth in Hong Kong.”
Ted Pitts, Global Supply Chain Manager at Ego, added, “KLN’s expertise in pharmaceutical logistics makes them an ideal partner to expand our reach in Hong Kong.”
KLN Pharma’s advanced warehouses, digital platforms, and specialized healthcare logistics team position the company to manage complex, regulated supply chains. With the global pharmaceutical logistics market expected to reach US$173 billion by 2030, KLN is well-placed to provide integrated, consumer-focused supply chain solutions.
The post KLN becomes 4PL partner for Ego Pharmaceuticals in Hong Kong appeared first on Container News.
